SCHEMBL24899346

SCHEMBL24899346

CNC(=O)[C@H](Cc1ccc(OCC(=O)O)cc1)NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@@H](C)Cc1ccc(OCC(=O)O)cc1

nearest known ligand 0.56

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MMP3 P08254 4/20 0.56
MMP9 P14780 3/20 0.53
MMP8 P22894 2/20 0.53
MMP2 P08253 2/20 0.52
MMP1 P03956 7/20 0.51
PTPN1 P18031 1/20 0.50
MME P08473 4/20 0.48
ACE P12821 4/20 0.48
CPA1 P15085 4/20 0.48
ACE2 Q9BYF1 4/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
PPARG P37231 1/20 0.47
PPARD Q03181 1/20 0.47
KLKB1 P03952 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27277512 0.96 MMP3 (0.53) MMP3MMP9MMP8MMP2MMP1
SCHEMBL24899384 0.95 MMP3 (0.52) MMP3MMP9MMP8MMP2MMP1
SCHEMBL24915280 0.91 GPR34 (0.54) MMP3MMP9MMP8MMP2MMP1
SCHEMBL26173250 0.90 PTPN1 (0.58) MMP3PTPN1MMEACECPA1
SCHEMBL26172463 0.89 MME (0.50) MMP3PTPN1MMEACECPA1
SCHEMBL26892213 0.89 MME (0.50) MMP3PTPN1MMEACECPA1
SCHEMBL26888062 0.88 PTPN1 (0.55) MMP3MMP1PTPN1MMEACE
SCHEMBL26889155 0.87 PTPN1 (0.57) PTPN1MMEACECPA1ACE2
SCHEMBL26173212 0.87 PTPN1 (0.57) PTPN1MMEACECPA1ACE2
SCHEMBL26875855 0.83 PTPN1 (0.53) PTPN1PPARGKLKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024059472-A1 MACROCYCLIC IMMUNOMODULATORS BRISTOL-MYERS SQUIBB COMPANY (US) 2024-03-21 WO disclosed
WO-2023004240-A1 MACROCYLIC IMMUNOMODULATORS BRISTOL-MYERS SQUIBB COMPANY (US) 2023-01-26 WO disclosed
WO-2023288213-A1 MACROCYCLIC IMMUNOMODULATORS BRISTOL-MYERS SQUIBB COMPANY (US) 2023-01-19 WO disclosed